Individual interactome networks for activated PD-1 and LAG-3 pathways or their combination were modelled (Fig. EV2D), and the correlation of the identified molecules with PDCD1/LAG3 expression was validated on human cancers with TIMER2.0 (Fig. EV2E). The gene discussed is LAG3; the disease is cancer.